VYNE Therapeutics Inc
NASDAQ:VYNE
| Market Cap (Intraday) | 31.72M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $2.52 |
| 50-Day MA | $2.40 |
| 200-Day MA | $3.18 |
VYNE Therapeutics Inc Stock, NASDAQ:VYNE
685 Route 202/206 North, Suite 301, Bridgewater, New Jersey 08807
United States of America
Phone: +1.800.755.7936
Number of Employees: 10
Description
VYNE Therapeutics, Inc. engages in the manufacture of pharmaceutical products. It develops and commercializes solutions using its proprietary Molecule Stabilizing Technology. Its commercial products include AMZEEQ and ZILXI. The company was founded in October 2011 and is headquartered in Bridgewater, NJ.